Activation of CD47 in T cells mainly leads to the suppression of their immune response, while the interaction of CD47 with SIRPα or TSP-1 induces proliferation and activation of antigen-specific T cells, thereby improving the immune response to cancer cells [51]. The gene discussed is SIRPA; the disease is cancer.